1Gupta M, Sharma P, Garg G. Plasma homocysteine: an independent or an interactive risk factor for coronary artery disease[J]. Clin Chim Aeta,2005,352(1/2):121-125.
2Bagi Z, Ungvari Z, Koller A. Xanthine oxidase-derived reactive oxygen species convert flow-induced arteriolar dilation to constriction in hyperhomocysteinemia: possible role of peroxynitrite[J]. Arterioscler Thromb Vasc Biol, 2002,22 ( 1 ) : 28-33.
3Majors AK,Sengupta S,Willard B,et al. Homocysteine binds to human plasma fibronneetie and inhibits its interaction with fibrin[J].Arterioseler Thromb Vase Biol, 2002, 22 (8) : 1354- 1359.
4Antonio CM,Nunes MC,Refsum H, et al. A novel pathway for the coversion of homocysteine to methionine in eukaryotes[J]. Biochem J, 1997,328(Pt 1) : 165-170.
6Bogaty P, Hackett D, Davies G, et al. Vasoreactivity of the culprit lesion in unstable angina[J]. Circulation, 1994,90 (1) : 5- 11.
7Stamter JS,Osborne JA,Jaraki O,et al. Adverse vascular effects of homoeysteine are modulated by endothelium-derived relaxing faetor and related oxides of nitrogen[J]. J Clin Invest, 1993,91 (1) :308-318.
8Adams MR, Robinson J, McCredie R, et al. Smooth muscle dysfunction occurs independently of impaired endothelium- dependent dilation in adults at risk of atherosclerosis[J].J Am Coil Cardiol, 1998,32(1 ) : 123-127.
二级参考文献1
1Suresh C Tyagi,Lane M Smiley,Vibhas S Mujumdar. Reduction-oxidation (Redox) and vascular tissue level of homocyst(e)ine in human coronary atherosclerotic lesions and role in extracellular matrix remodeling and vascular tone[J] 1998,Molecular and Cellular Biochemistry(1-2):107～116
6Wakil S M, Muiya N P, Tahir A I, et al. A new susceptibility locus for myocardial infarction, hypertension, type 2 diabetes mellitus, and dyslipidemia on chromosome 12q24[J]. Dis Markers,2014:291419.
7Kintscher U, Marx N, Martus P, et al. Effect of high-dose valsartan on inflammatory and lipid parameters in patients with Type 2 diabetes and hypertension[J]. Diabetes Res Clin Pract,2010,89(3):209-215.
8Miura S, Saku K. Efficacy and safety of angiotensin II type 1 receptor blocker/calcium channel blocker combination therapy for hypertension: focus on a single-pill fixed-dose combination of valsartan and amlodipine[J]. J Int Med Res,2012,40(1):1-9.
9Sun D, Huang A, Koller A, et al. Endothelial K(ca) channels mediate flow-dependent dilation of arterioles of skeletal muscle and mesentery[J]. Microvasc Res,2001,61(2):179-186.
10Atabek M E, Akyurek N, Eklioglu B S, et al. Impaired systolic blood dipping and nocturnal hypertension: an independent predictor of carotid intima-media thickness in type 1 diabetic patients[J]. J Diabetes Complications,2014,28(1):51-55.
